Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Fibrin Glue Sealant (Tisseel®) as a Reinforcement of Esophagojejunal Anastomoses Will Decrease the Rate of Anastomotic Leak.

NCT03733639 is registered in ClinicalTrials.gov with Germans Trias i Pujol Hospital as lead sponsor.

NCT NCT03733639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Fibrin Glue Sealant (Tisseel®) as a Reinforcement of Esophagojejunal Anastomoses Will Decrease the Rate of Anastomotic Leak.
Lead sponsor
Germans Trias i Pujol Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 21, 2020
Completion date
July 1, 2022
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anastomotic leak, gastric cancer